Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
about
Nuclear receptor coregulators: modulators of pathology and therapeutic targetsIdentification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data.A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.The function of steroid receptor coactivator-1 in normal tissues and cancer
P2860
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@ast
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@en
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
@nl
type
label
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@ast
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@en
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
@nl
prefLabel
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@ast
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@en
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
@nl
P2093
P2860
P50
P356
P1433
P1476
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
@en
P2093
Alexandra S Richter
Bernhard H F Weber
Christian Sutter
Claus R Bartram
Dieter Niederacher
Jimmy M Rae
Nina Ditsch
Peter Bugert
Sandrine Tchatchou
P2860
P2888
P356
10.1186/1471-2407-9-438
P407
P50
P577
2009-12-14T00:00:00Z
P5875
P6179
1007061527